SCHEMBL1011269

SCHEMBL1011269

CCC(O)C1(CC)COC1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3414473 0.82 EPHX1 (0.30) EPHX1
SCHEMBL1011876 0.82 EPHX1 (0.30) EPHX1
SCHEMBL9522789 0.80
SCHEMBL28504089 0.80 EPHX1 (0.35) EPHX1
SCHEMBL3416537 0.79
SCHEMBL3422310 0.79 ALDH1A1 (0.30)
SCHEMBL1010901 0.78
SCHEMBL3417846 0.77 GPR84 (0.34)
SCHEMBL16123673 0.76
SCHEMBL8024147 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6495636-B2 A 3-(ETHYLENEOXYALKYLOXYALKYL)OXETANE AND DERIVATIVES; COPOLYMERIZED WITH A 1,1-DIFLUOROETHYLENE OR DERIVATIVE; VERY COMPATIBLE AND COPOLYMERIZABLE WITH UNSATURATED COMPOUNDS; WATERPROOFING; RADIATION TRANSPARENT JSR CORPORATION (JP) 2002-12-17 US claimed
EP-4435064-B1 NONAQUEOUS INKJET INK AND METHOD FOR FORMING CURED PRODUCT KONICA MINOLTA INC (JP) 2026-04-22 EP disclosed
EP-4711426-A1 ACTIVE RAY-CURABLE INKJET INK COMPOSITION, METHOD FOR FORMING INSULATING FILM, INSULATING FILM, AND PRINTED WIRING BOARD KONICA MINOLTA, INC. (JP) 2026-03-18 EP disclosed
EP-4603551-A1 INKJET INK AND METHOD FOR PRODUCING THE SAME, METHOD FOR FORMING CURED PRODUCT, AND METHOD FOR STIRRING INKJET INK KONICA MINOLTA, INC. (JP) 2025-08-20 EP disclosed
EP-4600317-A1 INKJET INK, METHODS FOR PRODUCING PIGMENT DISPERSION AND INKJET INK, METHOD FOR FORMING CURED PRODUCT, AND CURED PRODUCT KONICA MINOLTA, INC. (JP) 2025-08-13 EP disclosed
EP-4534615-A1 ULTRAVIOLET CURABLE INK, METHOD FOR FORMING CURED PRODUCT, CURED PRODUCT, AND APPARATUS FOR FORMING CURED PRODUCT KONICA MINOLTA, INC. (JP) 2025-04-09 EP disclosed
EP-4530322-A1 INKJET INK, METHOD FOR FORMING CURED PRODUCT, AND CURED PRODUCT KONICA MINOLTA, INC. (JP) 2025-04-02 EP disclosed
CN-119708917-A Inkjet ink, method for forming cured product, and cured product 柯尼卡美能达株式会社 2025-03-28 CN disclosed
EP-4524210-A1 INKJET INK AND IMAGE FORMING METHOD KONICA MINOLTA, INC. (JP) 2025-03-19 EP disclosed
US-20250084271-A1 INKJET INK AND IMAGE FORMING METHOD Konica Minolta, Inc. (JP) 2025-03-13 US disclosed
US-20070060682-A1 Actinic radiation-curable stereolithographic resin composition having improved stability CMET INC. (JP) 2007-03-15 US disclosed
US-20070049651-A1 Curable composition, ink composition, inkjet recording method, printed material, method of producing planographic printing plate, planographic printing plate, and oxcetane compound FUJI PHOTO FILM CO., LTD. 2007-03-01 US disclosed
EP-1757635-A1 Curable modified oxetane compound and ink composition comprising it Fuji Photo Film Co., Ltd. (JP) 2007-02-28 EP disclosed
WO-2007001407-A2 LIGHT ACTIVATED SHAPE MEMORY CO-POLYMERS CORNERSTONE RESEARCH GROUP, INC. (US) 2007-01-04 WO disclosed
EP-1693427-A2 Ink for inkjet printing, lithographic printing plate using it and method for making such plate FUJI PHOTO FILM CO., LTD. (JP) 2006-08-23 EP disclosed
US-20060181591-A1 Ink for inkjet printing, lithographic printing plate using it and method for making such plate FUJI PHOTO FILM CO., LTD. 2006-08-17 US disclosed
US-20060141276-A1 Three-dimensional structure and method for production thereof CMET INC. (JP) 2006-06-29 US disclosed
US-6495636-B2 A 3-(ETHYLENEOXYALKYLOXYALKYL)OXETANE AND DERIVATIVES; COPOLYMERIZED WITH A 1,1-DIFLUOROETHYLENE OR DERIVATIVE; VERY COMPATIBLE AND COPOLYMERIZABLE WITH UNSATURATED COMPOUNDS; WATERPROOFING; RADIATION TRANSPARENT JSR CORPORATION (JP) 2002-12-17 US disclosed
US-20010002423-A1 Oxetane compound, oxetane copolymer, and process for producing the oxetane compound SUGIYAMA NAOKI (JP) 2001-05-31 US disclosed
EP-1095938-A1 OXETANE COMPOUNDS, OXETANE COPOLYMER, AND PROCESS FOR PRODUCING OXETANE COMPOUNDS JSR Corporation (JP) 2001-05-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010002423-A1 Oxetane compound, oxetane copolymer, and process for producing the oxetane compound OXER1, PYM1, AFF1 EPHX1 1209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.